Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kelch-like protein 42 (KLHL42) is a substrate-specific adaptor of the BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex, which is necessary for mitotic progression and cytokinesis[3][4][5]. The BCR(KLHL42) E3 ubiquitin ligase complex specifically mediates the ubiquitination and subsequent degradation of KATNA1, influencing microtubule dynamics throughout mitosis[5]. KLHL42 has a role in proteasome-mediated ubiquitin-dependent protein catabolic processes and the regulation of microtubule-based processes. Mutations in KLHL42 have been associated with Bardet-Biedl syndrome and Eiken syndrome[3]. The protein contains conserved domains characteristic of the Kelch-like gene family, specifically a BTB/POZ domain, a BACK domain, and Kelch repeats, and functions in assembling multiprotein E3 ubiquitin ligase complexes[1][3].
Drugs would typically act by modulating ubiquitination, affecting downstream protein stability and degradation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch-like protein 42 (KLHL42).